Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency-Reference-Cited by-同舟云学术

Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency

Published:2021-08 Issue: Volume:229 Page:108779
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Lanz Anna-Lisa,Riester Martin,Peters Philipp,Schwerd Tobias,Lurz Eberhard,Hajji Mohammad Samer,Rohlfs Meino,Ley-Zaporozhan Julia,Walz Christoph,Kotlarz Daniel,Klein Christoph,Albert Michael H.,Hauck Fabian

Funder

Else Kröner-Fresenius-Stiftung

Deutsches Zentrum für Infektionsforschung

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. The emerging role of CTLA-4 as an immune attenuator;Thompson;Immunity.,1997

2. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations;Schubert;Nat. Med.,2014

3. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4;Kuehn;Science.,2014

4. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects;Schwab;J. Allergy Clin. Immunol.,2018

5. Preponderance of CTLA4 variation associated with autosomal dominant immune dysregulation in the MYPPPY motif;Siggs;Front. Immunol.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inborn errors of immunity: A field without frontiers;Immunological Reviews;2023-12-08

2. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency;Journal of Allergy and Clinical Immunology;2023-12

3. The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma;Aging;2023-11-02

4. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders;Rheumatic Disease Clinics of North America;2023-11

5. Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement;Neurology;2023-10-10